GLP-1: The Game-Changer Investors Can't Ignore SteadyTrade

GLP-1 medications are a hot topic right now. Drugs like Novo Nordisk's (NVO) Ozempic and Eli Lilly's (LLY) Mounjaro are not only transforming individuals' weight loss and overall health… they're also presenting significant economic opportunities.On today's episode of the SteadyTrade Podcast, Tim Bohen and Matt McCall explore the revolutionary impact of these medications. Unlike traditional weight-loss methods – which can be challenging due to people's busy lifestyles – GLP-1 medications ...